Restricted accessResearch articleFirst published online 2021-09
Immunoglobulin A Autoreactivity toward Brain Enriched and Apoptosis-Regulating Proteins in Saliva of Athletes after Acute Concussion and Subconcussive Impacts
The diagnosis and management of concussion is hindered by its diverse clinical presentation and assessment tools reliant on subjectively experienced symptoms. The biomechanical threshold of concussion is also not well understood, and asymptomatic concussion or “subconcussive impacts” of variable magnitudes are common in contact sports. Concerns have risen because athletes returning to activity too soon have an increased risk of prolonged recovery or long-term adverse health consequences. To date, little is understood on a molecular level regarding concussion and subconcussive impacts. Recent research suggests that neuroinflammatory mechanisms may serve an important role subsequent to concussion and possibly to subconcussive impacts. These studies suggest that autoantibodies may be a valuable tool for detection of acute concussion and monitoring for changes caused by cumulative exposure to subconcussive impacts. Hence, we aimed to profile the immunoglobulin (Ig)A autoantibody repertoire in saliva by screening a unique sport-related head trauma biobank. Saliva samples (n = 167) were donated by male and female participants enrolled in either the concussion (24–48 h post-injury) or subconcussion (non-concussed participants having moderate or high cumulative subconcussive impact exposure) cohorts. Study design included discovery and verification phases. Discovery aimed to identify new candidate autoimmune targets of IgA. Verification tested whether concussion and subconcussion cohorts increased IgA reactivity and whether cohorts showed similarities. The results show a significant increase in the prevalence of IgA toward protein fragments representing 5-hydroxytryptamine receptor 1A (HTR1A), serine/arginine repetitive matrix 4 (SRRM4) and FAS (tumor necrosis factor receptor superfamily member 6) after concussion and subconcussion. These results may suggest that concussion and subconcussion induce similar physiological effects, especially in terms of immune response. Our study demonstrates that saliva is a potential biofluid for autoantibody detection in concussion and subconcussion. After rigorous confirmation in much larger independent study sets, a validated salivary autoantibody assay could provide a non-subjective quantitative means of assessing concussive and subconcussive events.
GizaC.C., and HovdaD. A. (2001). The neurometabolic cascade of concussion. J. Athl. Train. 36, 228–235.
3.
O'ConnorK.L., PeetersT., SzymanskiS., and BroglioS.P. (2017) Individual impact magnitude vs. cumulative magnitude for estimating concussion odds. Ann. Biomed. Eng. 45, 1985–1992.
4.
GuskiewiczK.M. and MihalikJ.P. (2011). Biomechanics of sport concussion: quest for the elusive injury threshold. Exerc. Sport Sci. Rev. 39, 4–11.
5.
HunterL.E., BranchC.A., and LiptonM.L. (2019). The neurobiological effects of repetitive head impacts in collision sports. Neurobiol. Dis. 123, 122–126.
6.
KoerteI.K., LinA.P., MuehlmannM., MerugumalaS., LiaoH., StarrT., KaufmannD., MayingerM., SteffingerD., FischB., KarchS., HeinenF., Ertl-WagnerB., ReiserM., SternR.A., ZafonteR., and ShentonM.E. (2015). Altered neurochemistry in former professional soccer players without a history of concussion. J Neurotrauma, 32, 1287–1293.
7.
ChurchillN.W., HutchisonM.G., Di BattistaA.P., GrahamS.J., and SchweizerT.A. (2017). Structural, functional, and metabolic brain markers differentiate collision versus contact and non-contact athletes. Front Neurol, 8, 390.
8.
Di BattistaA.P., ChurchillN., RhindS.G., RichardsD. and HutchisonM.G. (2020). The relationship between symptom burden and systemic inflammation differs between male and female athletes following concussion. BMC Immunol. 21, 11.
9.
CoughlinJ.M., WangY., MinnI., BienkoN., AmbinderE.B., XuX., PetersM.E., DoughertyJ.W., VranesicM., KooS.M., AhnH.H., LeeM., CottrellC., SairH.I., SawaA., MunroC.A., NowinskiC.J., DannalsR.F., LyketsosC.G., KassiouM., SmithG., CaffoB., MoriS., GuilarteT.R., and PomperM.G. (2017). Imaging of glial cell activation and white matter integrity in brains of active and recently retired National Football League players. JAMA Neurol. 74, 67–74.
10.
ShahimP., TegnerY., MarklundN., HöglundK., PorteliusE., BrodyD.L., BlennowK., and ZetterbergH. (2017). Astroglial activation and altered amyloid metabolism in human repetitive concussion. Neurology, 88, 1400–1407.
11.
JavidiE., and MagnusT. (2019). Autoimmunity after ischemic stroke and brain injury. Front. Immunol. 10, 686.
12.
RaadM., NohraE., ChamsN., ItaniM., TalihF., MondelloS., and KobeissyF. (2014). Autoantibodies in traumatic brain injury and central nervous system trauma. Neuroscience, 281, 16–23.
13.
ZhangZ., ZoltewiczJ.S., MondelloS., NewsomK.J., YangZ., YangB., KobeissyF., GuingabJ., GlushakovaO., RobicsekS., HeatonS., BukiA., HannayJ., GoldM.S., RubensteinR., LuX.C., DaveJ.R., SchmidK., TortellaF., RobertsonC.S., and WangK.K. (2014). Human traumatic brain injury induces autoantibody response against glial fibrillary acidic protein and its breakdown products. PLoS One, 9, e92698.
14.
MarchiN., BazarianJ.J., PuvennaV., JanigroM., GhoshC., ZhongJ., ZhuT., BlackmanE., StewartD., EllisJ., ButlerR., and JanigroD. (2013). Consequences of repeated blood–brain barrier disruption in football players. PLoS One, 8, e56805.
15.
SteinT.D., FedynyshynJ.P., KalilR.E. (2002). Circulating autoantibodies recognize and bind dying neurons following injury to the brain. J. Neuropathol. Exp. Neurol. 61, 1100–1108.
16.
ZhangC.Z., ChengX.Q., LiJ.Y., ZhangP., YiP., XuX., and ZhouX.D. (2016). Saliva in the diagnosis of diseases. Int. J. Oral Sci. 8, 133–137.
17.
JohnsonJ.J., LoeffertA.C., StokesJ., OlympiaR.P., BramleyH., and HicksS.D. (2018). Association of salivary microRNA changes with prolonged concussion symptoms. JAMA Pediatr. 172, 65–73.
18.
IkunoN., MackayI.R., JoisJ., OmagariK., and RowleyM.J. (2001). Antimitochondrial autoantibodies in saliva and sera from patients with primary biliary cirrhosis. J. Gastroenterol. Hepatol. 16, 1390–1394.
19.
AyogluB., SchwenkJ.M., and NilssonP. (2016). Antigen arrays for profiling autoantibody repertoires. Bioanalysis, 8, 1105–1126.
20.
BerglundL., BjörlingE., OksvoldP., FagerbergL., AsplundA., SzigyartoC. A., Persson, A., Ottosson, J., Wernérus, H., Nilsson, P., Lundberg, E., Sivertsson, A., Navani, S., Wester, K., Kampf, C., Hober, S., Pontén, F., Uhlén, M., A genecentric Human Protein Atlas for expression profiles based on antibodies. Mol Cell Proteomics 2008, 7 (10), 2019–27.
21.
AyogluB., MitsiosN., KockumI., KhademiM., ZandianA., SjöbergR., ForsströmB., BredenbergJ., Lima BomfimI., HolmgrenE., GrönlundH., Guerreiro-CacaisA. O., AbdelmagidN., UhlénM., WaterboerT., AlfredssonL., MulderJ., SchwenkJ.M., OlssonT., and NilssonP. (2016). Anoctamin 2 identified as an autoimmune target in multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A. 113, 2188–2193.
22.
TengvallK., HuangJ., HellströmC., KammerP., BiströmM., AyogluB., Lima BomfimI., StridhP., ButtJ., BrennerN., MichelA., LundbergK., PadyukovL., LundbergI.E., SvenungssonE., ErnbergI., OlafssonS., DiltheyA.T., HillertJ., AlfredssonL., SundströmP., NilssonP., WaterboerT., OlssonT., and KockumI. (2019). Molecular mimicry between Anoctamin 2 and Epstein–Barr virus nuclear antigen 1 associates with multiple sclerosis risk. Proc. Natl. Acad. Sci. U. S. A. 116, 16, 955–16,960.
23.
Häggmark-MånbergA., ZandianA., ForsströmB., KhademiM., Lima BomfimI., HellströmC., Arnheim-DahlströmL., HallböökT., DarinN., LundbergI.E., UhlénM., PartinenM., SchwenkJ.M., OlssonT., and NilssonP. (2016). Autoantibody targets in vaccine-associated narcolepsy. Autoimmunity, 49, 421–433.
24.
PinE., HenjesF., HongM.G., WiklundF., MagnussonP., BjartellA., UhlénM., NilssonP., and SchwenkJ.M. (2017). Identification of a novel autoimmune peptide epitope of prostein in prostate cancer. J. Proteome Res. 16, 204–216.
25.
CaswellS.V., LincolnA.E., AlmquistJ.L., DunnR.E., and HintonR.Y. (2012). Video incident analysis of head injuries in high school girls' lacrosse. Am. J. Sports Med. 40, 756–762.
26.
CaswellS.V., LincolnA.E., StoneH., KelshawP., PutukianM., HepburnL., HigginsM., CortesN. (2017). Characterizing verified head impacts in high school girls' lacrosse. Am. J. Sports Med. 45, 3374–3381.
27.
CortesN., LincolnA.E., MyerG.D., HepburnL., HigginsM., PutukianM., and CaswellS.V. (2017). Video analysis verification of head impact events measured by wearable sensors. Am. J. Sports Med. 45, 2379–2387.
28.
LincolnA.E., CaswellS.V., AlmquistJ.L., DunnR.E., and HintonR.Y. (2013). Video incident analysis of concussions in boys' high school lacrosse. Am. J. Sports Med. 41, 756–761.
29.
NavazeshM. (1993). Methods for collecting saliva. Ann. N. Y. Acad. Sci. 694, 72–77.
30.
AgatonC., GalliJ., Höidén GuthenbergI., JanzonL., HanssonM., AsplundA., BrundellE., LindbergS., RuthbergI., WesterK., WurtzD., HöögC., LundebergJ., StåhlS., PonténF., and UhlénM. (2003). Affinity proteomics for systematic protein profiling of chromosome 21 gene products in human tissues. Mol. Cell Proteomics, 2, 405–414.
31.
NilssonP., PaavilainenL., LarssonK., OdlingJ., SundbergM., AnderssonA C., KampfC., PerssonA., Al-Khalili SzigyartoC., OttossonJ., BjörlingE., HoberS., WernérusH., WesterK., PonténF., and UhlenM. (2005). Towards a human proteome atlas: high-throughput generation of mono-specific antibodies for tissue profiling. Proteomics, 5, 4327–4337.
32.
HumphreyS.P., and WilliamsonR.T. (2001). A review of saliva: normal composition, flow, and function. J. Prosthet. Dent. 85, 162–169.
33.
LeeY.H., and WongD.T. (2009). Saliva: an emerging biofluid for early detection of diseases. Am. J. Dent. 22, 241–248.
34.
WangX., Kaczor-UrbanowiczK.E. and WongD.T. (2017). Salivary biomarkers in cancer detection. Med. Oncol. 34, 7.
35.
HuS., WangJ., MeijerJ., IeongS., XieY., YuT., ZhouH., HenryS., VissinkA., PijpeJ., KallenbergC., ElashoffD., LooJ.A., and WongD.T. (2007). Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome. Arthritis Rheum. 56, 3588–3600.
36.
AdamD.J., MilneA.A., EvansS.M., RoulstonJ.E., LeeA.J., RuckleyC.V., and BradburyA.W. (1999). Serum amylase isoenzymes in patients undergoing operation for ruptured and non-ruptured abdominal aortic aneurysm. J. Vasc. Surg. 30, 229–235.
37.
WuC.C., ChangY.T., ChangK.P., LiuY.L., LiuH.P., LeeI.L., YuJ.S., ChiangW.F. (2014). Salivary auto-antibodies as noninvasive diagnostic markers of oral cavity squamous cell carcinoma. Cancer Epidemiol. Biomarkers Prev. 23, 1569–1578.
38.
MarkopoulosA.K., BelaziM.A., and DrakoulakosD. (1997). Glutamic acid decarboxylase autoantibodies in saliva of children with type 1 diabetes. Diabetes Res. Clin. Pract. 38, 169–172.
39.
GrosjeanM.B., LenzlingerP.M., StahelP.F., YatsivI., ShohamiE., TrentzO., KossmannT., and Morganti-KossmannM.C. (2007). Immunohistochemical characterization of Fas (CD95) and Fas ligand (FasL/CD95L) expression in the injured brain: relationship with neuronal cell death and inflammatory mediators. Histol. Histopathol. 22, 235–250.
40.
PolterA.M., and LiX. (2010). 5-HT1A receptor-regulated signal transduction pathways in brain. Cell Signal, 22, 1406–1412.
41.
VanderploegR.D., CurtissG., LuisC.A., and SalazarA.M. (2007). Long-term morbidities following self-reported mild traumatic brain injury. J. Clin. Exp. Neuropsychol. 29, 585–598.
42.
SmythK., SandhuS.S., CrawfordS., DeweyD., ParboosinghJ., and BarlowK.M. (2014). The role of serotonin receptor alleles and environmental stressors in the development of post-concussive symptoms after pediatric mild traumatic brain injury. Dev. Med. Child Neurol. 56, 73–7.
43.
StarońJ., BugnoR., HogendorfA.S., and BojarskiA.J. (2018). 5-HT1A receptor ligands and their therapeutic applications: review of new patents. Expert Opin Ther Pat, 28, 679–689.
44.
JassamY.N., IzzyS., WhalenM., McGavernD.B., and El KhouryJ. (2017). Neuroimmunology of traumatic brain injury: time for a paradigm shift. Neuron, 95, 1246–1265.
45.
SimonD.W., McGeachyM.J., BayırH., ClarkR.S., LoaneD.J., and KochanekP.M. (2017). The far-reaching scope of neuroinflammation after traumatic brain injury. Nat. Rev. Neurol. 13, 171–191.
46.
PattersonZ.R., and HolahanM.R. (2012). Understanding the neuroinflammatory response following concussion to develop treatment strategies. Front. Cell Neurosci. 6, 58.
47.
BrandtzaegP. (2013). Secretory immunity with special reference to the oral cavity. J Oral, Microbiol, 5 [Epub ahead of print].
48.
BroglioS.P., LapointeA., O'ConnorK.L., and McCreaM. (2017). Head impact density: a model to explain the elusive concussion threshold. J. Neurotrauma, 34, 2675–2683.
49.
CovassinT., PetitK.M., SavageJ.L., BretzinA.C., FoxM.E., WalkerL.F., and GouldD. (2018). Sports-related concussion occurrence at various time points during high school athletic events: Part 2. Am. J. Sports Med. 46, 2270–2276.
50.
KerrZ.Y., CortesN., CaswellA.M., AmbegaonkarJ.P., HallsmithK.R., MilbertA.F., and CaswellS.V. (2017). Concussion rates in U.S. middle school, athletes, 2015–2016 school year. Am. J. Prev. Med. 53, 914–918.
51.
McCroryP., Feddermann-DemontN., DvořákJ., CassidyJ.D., McIntoshA., VosP.E., EchemendiaR.J., MeeuwisseW., TarnutzerA.A. (2017). What is the definition of sports-related concussion: a systematic review. Br. J. Sports Med. 51, 877–887.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
